Dosidal · Switzerland

Bortezomib Sandoz, Pulver zur Herstellung einer Injektionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:67167 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 67167
atc: L01XG01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2018-11-13
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01XG01
authorisation_number: 67167
form: PULPA
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 07.16.1.
name: Bortezomib Sandoz, Pulver zur Herstellung einer Injektionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
ppn15bAKon3xTTkolN0nDUMMKqduaeTy7JE7IZxhh8O0FMnq65jYRtncoykC-kMntSwA68wkNFLGAbUwkv1KRQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:67167 · Same medicine in other markets · Dosidal